Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02419703 · ClinicalTrials.gov registry record
The STAR™ Tumor Ablation Registry
A clinical trial, sponsored by Merit Medical Systems.
- Terminated
- Registry status
- 65
- Enrollment target
NCT02419703 is a clinical trial that was terminated before completion, run by Merit Medical Systems. The registered enrollment target is 65 participants.
The verdict
NCT02419703 was terminated before completion, sponsored by Merit Medical Systems.
- TERMINATED
- Registry status
- 65 participants
- Enrollment target
Study Summary
Registry collecting data on use of The STAR™ Tumor Ablation System.
Interventions
- DEVICE STAR™ Tumor Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-03-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02419703
The ClinicalTrials.gov registry entry for NCT02419703 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merit Medical Systems, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which STAR™ Tumor Ablation System is the first listed.
NCT02419703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02419703 about?
NCT02419703 is a clinical study titled "The STAR™ Tumor Ablation Registry". Registry collecting data on use of The STAR™ Tumor Ablation System.
What is the current status of trial NCT02419703?
This trial is currently terminated. The enrollment target is 65 participants. The study started on 2015-10. Estimated completion is 2017-03-20.
What interventions are being tested in trial NCT02419703?
The interventions under investigation include: STAR™ Tumor Ablation System (DEVICE).
Who is sponsoring clinical trial NCT02419703?
This trial is sponsored by Merit Medical Systems, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.